Singapore – Talk Bio

Flagship’s Winning Streak Continues with Singapore R&D Partnership

7 months ago talkbio0Tagged Collaboration, Flagship, innovation, R&D, Singapore

Flagship, R&D collaboration, Singapore, biotech, innovation

Pfizer Expands API Manufacturing Site in Singapore with $740M+ Investment

9 months ago talkbio0Tagged alpha 1-antitrypsin, Extension, Facility (object), Investments, Manufacture, Pfizer, Singapore

Pfizer, API manufacturing, Singapore, facility extension, investment

AstraZeneca Invests $1.5 Billion in Singapore for Comprehensive Antibody-Drug Conjugate Manufacturing

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, Investments, Manufacture, production, Singapore

AstraZeneca, Singapore, antibody-drug conjugate (ADC), manufacturing, investment, biotechnology, pharmaceuticals, end-to-end production, cancer treatment.

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.

AbbVie pours $223M into building out its biologics capacity in Singapore

1 year ago talkbio0Tagged AbbVie, Biological Factors, Capacity, expansion, Investments, Manufacture, Singapore

Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore